Arabidopsis gene identifiers (e.g., At5gXXXXX) follow a standardized format where "At" denotes Arabidopsis thaliana, "5" indicates chromosome 5, and "g" signifies a gene locus. While the search results do not explicitly mention At5g48605, several studies highlight antibodies targeting Arabidopsis proteins with similar nomenclature patterns:
AtSYP32 (Syntaxin of Plants 32): A protein involved in pollen tube cell wall development, studied using polyclonal antibodies to detect its localization and function in secretion pathways .
AtLURE1: Defensin-like peptides critical for pollen tube guidance, analyzed via anti-CRP810_1.2 antibodies .
These examples demonstrate that antibodies against Arabidopsis proteins are often named after their target gene identifiers (e.g., anti-AtSYP32).
Antibody validation is critical to avoid cross-reactivity or false signals, as highlighted by studies on anti-glucocorticoid receptor antibodies (e.g., clone 5E4) and anti-DEFA5 antibodies . Key validation steps include:
Immunoblotting: Confirming target protein size (e.g., AtSYP32 detected at ~35 kDa) .
Immunofluorescence: Localizing proteins in specific tissues (e.g., pollen tube tips) .
Functional assays: Testing antibody effects on cellular processes (e.g., cellulose biosynthesis in atsyp32 mutants) .
If At5g48605 encodes a protein of interest, its hypothetical antibody could be used for:
Sequence Similarity: Paralogs (e.g., AtSYP31 and AtSYP32) may require isoform-specific antibodies .
Cross-Reactivity: Antibodies against conserved domains (e.g., defensins) may bind unintended targets .
Validation: Rigorous testing (e.g., immunoprecipitation, mass spectrometry) is essential to confirm specificity .
No direct references to At5g48605 were found in the provided sources. To advance studies on this target:
Gene Characterization: Clarify the function of At5g48605 through transcriptomic or proteomic profiling.
Antibody Production: Develop monoclonal or polyclonal antibodies using recombinant protein fragments.
Validation: Apply orthogonal methods (e.g., CRISPR knockout lines) to confirm antibody specificity .